The Alliance for Connected Care submitted input on the Office of National Drug Control Policy’s 2026 National Drug Control Strategy. The Alliance emphasized the importance of maintaining comprehensive access to telehealth, because it is often an essential part of treatment for mental health conditions and substance use disorders and supports long-term recovery. The Alliance urged ONDCP [...]
The Alliance submitted a response to the Department of Justice Anticompetitive Regulations Task Force request for public comment to identify unnecessary laws and regulations that raise the highest barriers to competition. The Alliance for Connected Care (the “Alliance”) outlines four areas where we hope the Department of Justice Task Force will focus to improve care [...]
The Alliance submitted a response to the Federal Trade Commission's request for public comment regarding reducing anti-competitive regulatory barriers in health care. Our health care system is deeply impacted by anticompetitive practices. The Alliance appreciates the Federal Trade Commission’s long-standing work to reform occupational licensing regulations, removing anticompetitive practices. In particular, the FTC investigated options [...]
The Alliance appreciates the DEA’s forward movement on telemedicine prescribing of controlled substances policy. However, the Alliance continues to be concerned to see language in the proposed rulemaking mandating in-person visits as this is not an appropriate guardrail for a telehealth service. Similarly, restricting the geography in which telemedicine can be offered undermines the value [...]
The Alliance for Connected Care led a letter, signed by more than 150 organizations, to the Attorney General Pam Bondi requesting her leadership in maintaining the access to telehealth that President Trump initiated during his first term. More than 150 organizations have signed this letter, including business groups like the Small Business & Entrepreneurship Council and [...]
ALLIANCE STATEMENT DRUG ENFORCEMENT ADMINISTRATION (DEA) RELEASES SPECIAL REGISTRATION PROPOSAL JANUARY 2025 The Alliance for Connected Care appreciates the Drug Enforcement Administration’s (DEA) forward movement on telemedicine prescribing of controlled substances policy. Today, the DEA released a notice of proposed rulemaking, which would establish a special registration framework and authorize three types of special registrations [...]
FOR IMMEDIATE RELEASE MEDIA CONTACT Krista Drobac; kdrobac@connectwithcare.org Hundreds of Stakeholders Call on Federal Leaders to Ensure Patient Care is Not Interrupted by Expiring Prescribing Flexibilities WASHINGTON, D.C. September 10, 2024 – Today, more than 300 organizations asked Congress and the White House to intervene to ensure ongoing access to virtual prescribing for patients and [...]
Last week, we finally saw a proposed rule – “Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have not had a Prior In-Person Medical Evaluation” arrive at OMB. We expect that this proposed rule will avert the current end of telehealth prescribing flexibility on December 31, 2024. However, there remains significant risk [...]
Mental Health Groups Sent Letter on Schedule IIN Non-Narcotic Prescribing Mental health groups are pushing the agency to allow Schedule IIN non-narcotic drugs to be prescribed without an in-person visit. Those include stimulants used to treat attention-deficit/hyperactivity disorder. A coalition of mental health groups, including the American Psychiatric Association, the American Academy of Pediatrics [...]
The Alliance for Connected Care joined over 45 organizations in a statement to the Drug Enforcement Administration (DEA), requesting explicit guidance to the pharmacy community that the geography of a prescriber in relation to the patient or the pharmacy should not be a "red flag" when a prescription is a result of a telehealth [...]